New data from a recent market study shows that, while pharmacists overwhelmingly agree that recently released vancomycin dosing guidelines are important to patient safety, a minority have plans in place to adopt them. InsightRX surveyed 126 hospital pharmacy leaders to gauge their awareness of the guidelines, thoughts about the value of adopting them, and plans to implement.

We’ve put together a panel of experts from across the industry to share their insights:

  • Sirj Goswami, PhD: CEO & Co-Founder, InsightRX
  • Rita Jew, PharmD, FASHP: Principal, RKJ Health Partners
  • Julie Giddens, PharmD, BCPS-AQID, BCIDP: Ministry Infectious Disease Pharmacotherapy Coordinator, OSF Healthcare
  • Dan D’Orazio: CEO, Sage Growth Partners
  • Jeffery Laux, PharmD, BCIDP: Clinical Pharmacy Specialist, Covenant HealthCare
This group will discuss the benefits and challenges of adopting these guidelines amid the current pandemic. Through a lively discussion, participants will gain new insights on how precision dosing can make a meaningful impact on patient safety—while improving cost and time savings for clinical pharmacies.

Featured Speakers

Sirj Goswami, PhD

CEO & Co-Founder
InsightRX

Sirj Goswami is CEO and co-founder of InsightRX. As a Discovery Fellow at UCSF, Sirj received a PhD from the department of Bioengineering and Therapeutic Sciences, with a research focus in genomics, pharmacokinetics, and pharmacometrics. After four years of research experience at Genentech and Pfizer, Sirj founded InsightRX. His passion lies in bringing genomics and advanced analytics to the forefront of healthcare.

Rita Jew, PharmD, FASHP

Principal
RKJ Health Partners

Dr. Jew is Principal of RKJ Health Partners, where she provides consultative services in pharmacy operations, medication safety, pharmacy finance, specialty pharmacy, sterile compounding and extemporaneous formulations, and leadership training. Prior to starting her own consulting business, she held various leadership positions at children’s hospitals and health-system pharmacies. Her 25 plus-year tenure in hospital pharmacies encompassed broad experiences in pharmacy leadership, clinical pharmacy services, and more. Dr. Jew received her Pharm.D. from University of California at San Francisco.

Dan D'Orazio

CEO
Sage Growth Partners

As CEO of Sage Growth Partners, LLC (SGP), Dan D’Orazio shapes and leads the vision for the firm—a vision focused on helping clients to accelerate their commercial growth. Dan’s career includes extensive experience in value-creation, strategic advisory, marketing, and project launches for non-profit/public sectors as well as the corporate world. Dan has worked extensively with healthcare service providers, technology and device companies, payers, and provider organizations, and private equity/venture capitalists—with firms ranging from startups to Fortune 10 companies.

Julie Giddens, PharmD, BCPS-AQID, BCIDP

Ministry Infectious Disease Pharmacotherapy Coordinator
OSF Healthcare

Julie Giddens is an infectious disease pharmacy coordinator for OSF HealthCare, a 14-facility health system based in Peoria, IL. She was previously the infectious disease clinical pharmacist at St. Joseph Hospital in Denver, CO. After receiving her PharmD from Purdue University, Julie completed a General Inpatient PGY-1 and Infectious Disease PGY-2 with IU Health in Indianapolis, IN. She enjoys hiking, reading, and swimming with her four children.

Jeffery Laux, PharmD, BCIDP

Clinical Pharmacy Specialist
Covenant HealthCare

Jeff Laux is a clinical pharmacy specialist with emphasis in critical care and infectious disease/antimicrobial stewardship at Covenant HealthCare in Saginaw, Michigan. He received his bachelor’s degree in Pharmacy from Ferris State University in Big Rapids, Michigan and his doctor of pharmacy degree from Northern Ohio University in Ada, Ohio.

NOW AVAILABLE ON-DEMAND

Register now for this webinar